2Aranda JM,Schofield RS,Leach D,et al.Ventricular dyssynchronyin dilated cardiomyopathy:the role of biventricular pacing in thetreatment of congestive heart failure.Clin Cardio,l 2002,25:357-62. 被引量：1
3Abraham W.Rationale and design of a randomized clinicahriai to assess the safety and efficacy of cardiac resynchro-nization therapy in patients with advanced heart failure:The Multicenter lnsync Randomized Clinical Evaluation(MIRACLE).J of Cardiac Failure,2000,6:369-380. 被引量：1
4YU CM,BleekerGB,Fung JWH,et al.Left ventricular reverse remodellng but not clinicai improvement predicts longterm survival after cardiaC resynchronization therapy.Circulation,2005,112:1580-1586. 被引量：1
1Xiao HB, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol, 1996,53 : 163-170. 被引量：1
2Gras D, Mabo P, Yang T, et al. Multisite pacing as a supplemental treatment of chronic heart failure: preliminary results of the Medtronic InSync Study. PACE, 1998,21:2249-2255. 被引量：1
3Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Eng J Med, 2001,344:873-880. 被引量：1
4Abraham W.Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure:the Multicenter InSync Randomized Clinical Evaluation(MIRACLE).J Cardiac Failure,2000,6:369-380. 被引量：1
5Molhoek SG,Bax JJ,Erven LV,et al.Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.Am J Cardiol,2004,93:860-863. 被引量：1
6Popone C,Auricchio A,Schalij M,et al.Can tansvenous left ventricular leads be used as standard treatment for heart failure patients?The European experience with the first 1000 over-the-wire lead implantation.PACE,2001,24:619. 被引量：1
7Cleland JG,Daubert JC,Erdmann E,et al.The effect of cardiac resynchronization on morbidity and mortality in heart failure.N Engl J Med,2005,352:1539-1549. 被引量：1
2Costanzo MR.Ultrafiltration in the management of heart failure[J].Curr Opin Crit Care,2008,14(5):524-530. 被引量：1
3Hunt SA,Abraham WT,Chin MH,et al.2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation[J].J Am Coll Cardiol,2009,53(15):e1-e90. 被引量：1
4Malcom J,Arnold O,Howlett JG,et al.Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update:best practices for the transition of care of heart failure patients,and the recognition,investigation and treatment of cardiomyopathies[J].Can J Cardiol,2008,24(1):21-40. 被引量：1
5Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC(HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM)[J].Eur J Heart Fail,2008,10(10):933-989. 被引量：1
